Joe is a classically trained journalist who’s been writing about the auto industry and car culture for 40 years, steering the editorial direction of prominent Canadian magazines such as World of ...
Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup right on the heels of a similar deal unveiled earlier this month. For up to $670 million, Fosun is ...
The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a life-threatening syndrome responsible for over ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced that the U.S. Food and Drug ...
SetPoint System offers the first clinically-proven neuromodulation treatment option for rheumatoid arthritis (RA) SetPoint Medical, a company dedicated to developing therapies for people living with ...
Credit: SetPoint Medical. The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve. In a phase 3 study, the SetPoint neuroimmune ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 16, the rezpegaldesleukin group saw more lesion ...
Abstract: Single sideband (SSB) modulation enables high spectral efficiency, and ensures high throughput performance when combined with discrete multitone (DMT) modulation. The conventional approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback